Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chenodeoxycholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112341512A details a novel route converting seal cholic acid to chenodeoxycholic acid, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Patent CN120081889B reveals a one-pot hydrogenation method for high-purity chenodeoxycholic acid, offering significant cost reduction in API manufacturing and scalable production.
Patent CN107573396B details a novel two-step chromatography method achieving >97.5% purity CDCA. Ideal for reliable pharmaceutical intermediates supply chains.
Patent CN111410675A reveals a low-cost oxidation method for 3 7-diketocholanic acid. Enhances purity and yield for pharmaceutical intermediates manufacturing supply chains.
Patent CN102766185A details a novel method for recovering ursodesoxycholic acid and chenodeoxycholic acid from waste mother liquor, offering significant cost reduction and supply chain reliability.
Discover a novel synthetic route for ursodesoxycholic acid from chenodeoxycholic acid featuring high optical purity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105418716A details a novel duck bile extraction method for Chenodeoxycholic acid. This process ensures high purity and significant cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN1912192B reveals a green electrochemical route for 7-keto lithocholic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel chenodeoxycholic acid route offers high purity lithocholic acid. Safe reagents and scalable process reduce manufacturing costs for pharmaceutical supply chains.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106831923B reveals a novel CDCA synthesis route. Discover high-purity manufacturing, supply chain reliability, and significant cost reduction strategies.
Novel patent CN112724189B details waste-to-value synthesis enhancing supply chain reliability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Patent CN107200763B reveals a novel two-step synthesis for lithocholic acid. This method offers high purity and scalable production for pharmaceutical supply chains.
Patent CN103319560A details a high-yield UDCA synthesis from CDCA using NBS oxidation and Luche reduction, offering cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.
Patent CN106046095A reveals mild synthesis route. Reduces LDA use significantly. Reliable supply chain partner for commercial scale-up and high purity API intermediates.